View in EDS HTML Full Text PDF Full Text

Romidepsin and mogamulizumab sequential treatment for advanced cutaneous T-cell lymphoma.

Saved in:
Bibliographic Details
Title: Romidepsin and mogamulizumab sequential treatment for advanced cutaneous T-cell lymphoma.
Authors: Gordon ER; Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA., Tolu S; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA., Lapolla BA; Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA., Trager MH; Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA., Adeuyan O; Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA., Pazos MA; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA., Piorczynski T; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA., DeStephano D; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA., Bates SE; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA., Pro B; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA., Amengual JE; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA., Geskin LJ; Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.; Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2025 Dec; Vol. 66 (12), pp. 2277-2284. Date of Electronic Publication: 2025 Aug 11.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40788987
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Romidepsin and mogamulizumab sequential treatment for advanced cutaneous T-cell lymphoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gordon+ER%22">Gordon ER</searchLink>; Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Tolu+S%22">Tolu S</searchLink>; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Lapolla+BA%22">Lapolla BA</searchLink>; Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Trager+MH%22">Trager MH</searchLink>; Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Adeuyan+O%22">Adeuyan O</searchLink>; Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Pazos+MA%22">Pazos MA</searchLink>; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Piorczynski+T%22">Piorczynski T</searchLink>; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22DeStephano+D%22">DeStephano D</searchLink>; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Bates+SE%22">Bates SE</searchLink>; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Pro+B%22">Pro B</searchLink>; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Amengual+JE%22">Amengual JE</searchLink>; Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Geskin+LJ%22">Geskin LJ</searchLink>; Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.; Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2025 Dec; Vol. 66 (12), pp. 2277-2284. <i>Date of Electronic Publication: </i>2025 Aug 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40788987
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10428194.2025.2542941
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2277
    Titles:
      – TitleFull: Romidepsin and mogamulizumab sequential treatment for advanced cutaneous T-cell lymphoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gordon ER
      – PersonEntity:
          Name:
            NameFull: Tolu S
      – PersonEntity:
          Name:
            NameFull: Lapolla BA
      – PersonEntity:
          Name:
            NameFull: Trager MH
      – PersonEntity:
          Name:
            NameFull: Adeuyan O
      – PersonEntity:
          Name:
            NameFull: Pazos MA
      – PersonEntity:
          Name:
            NameFull: Piorczynski T
      – PersonEntity:
          Name:
            NameFull: DeStephano D
      – PersonEntity:
          Name:
            NameFull: Bates SE
      – PersonEntity:
          Name:
            NameFull: Pro B
      – PersonEntity:
          Name:
            NameFull: Amengual JE
      – PersonEntity:
          Name:
            NameFull: Geskin LJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1029-2403
          Numbering:
            – Type: volume
              Value: 66
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Leukemia & lymphoma
              Type: main
ResultId 1